Cases & Deals

  • Home
  • Practices
  • Guided Therapeutics issues $2.6 million of Convertible Preferred Stock and Warrants in private placement

Share

Guided Therapeutics issues $2.6 million of Convertible Preferred Stock and Warrants in private placement

May 2013

Client(s) Guided Therapeutics, Inc

Jones Day advised Guided Therapeutics, Inc., a medical device company developing a biophotonic cancer detection testing platform, in connection with a $2.6 million private placement to accredited investors of Convertible Preferred Stock and Warrants to purchase shares of Common Stock.

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.